https://www.pharmaradar360.com/article/d7cfe8927d4d3d9ePharmaRadar360en2026-04-09T07:00:00.000ZA simple model makes it possible to predict which patients experiencing a first psychotic episode will recover during the first yearhttps://www.pharmaradar360.com/article/788aa52547e7c5b1PharmaRadar360en2026-04-09T05:19:13.000ZNovartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030https://www.pharmaradar360.com/article/9a8cc9f87b8f7864PharmaRadar360en2026-04-09T02:00:00.000ZPharmac to fund two new combination treatments, and widen access to another, for people with a type of blood cancerhttps://www.pharmaradar360.com/article/cd0c881f416c0fadPharmaRadar360en2026-04-09T00:00:00.000ZOrion’s production processes in Turku, Finland to become carbon free with new steam plant4/9/2026 Sustainabilityhttps://www.pharmaradar360.com/article/f962f98b2e2e660dPharmaRadar360en2026-04-09T00:00:00.000ZIdorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Developmenthttps://www.pharmaradar360.com/article/e0c28c2be852c373PharmaRadar360en2026-04-09T00:00:00.000Znews releases enhttps://www.pharmaradar360.com/article/ab64493bb687833fPharmaRadar360en2026-04-09T00:00:00.000ZImmunic to Participate in Scientific and Medical Conferences in Aprilhttps://www.pharmaradar360.com/article/a6d04440b8d67e7bPharmaRadar360en2026-04-09T00:00:00.000ZLatest Researchhttps://www.pharmaradar360.com/article/19f59684ccd74cc6PharmaRadar360en2026-04-09T00:00:00.000ZGeliose Mobility, an IIT Delhi incubated startup, launches ‘HOPE’, an affordable electric scooter for last mile delivery and personal commutehttps://www.pharmaradar360.com/article/03ef8f9a85223c81PharmaRadar360en2026-04-08T22:14:37.000ZBlaine Labs, Inc Issues Voluntary Nationwide Recall of Wound Care Gel Products Due to Microbial Contaminationhttps://www.pharmaradar360.com/article/194ed91c950cdccbPharmaRadar360en2026-04-08T22:00:00.000ZInvestor Access Event (Paris, France)https://www.pharmaradar360.com/article/9d1cf1d163d8a595PharmaRadar360en2026-04-08T21:18:56.000ZPatient Listening Session Summarieshttps://www.pharmaradar360.com/article/875a9550a96e7914PharmaRadar360en2026-04-08T20:09:24.000ZFDA approves safety labeling changes for opioid pain medicineshttps://www.pharmaradar360.com/article/991e22be9f881505PharmaRadar360en2026-04-08T20:09:03.000ZFDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chainhttps://www.pharmaradar360.com/article/bbb4a3a020ed9a96PharmaRadar360en2026-04-08T20:06:06.000ZFDA's ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neurosciencehttps://www.pharmaradar360.com/article/e7b337dbb00bb1d2PharmaRadar360en2026-04-08T20:05:23.000ZFDA revises letter of authorization for the emergency use authorization for Paxlovidhttps://www.pharmaradar360.com/article/4beffe81f1abf7ecPharmaRadar360en2026-04-08T19:57:52.000ZACRP Fellow Touts the Benefits of Bringing Clinical Research Stakeholders Togetherhttps://www.pharmaradar360.com/article/b68d421386b21a7ePharmaRadar360en2026-04-08T19:45:40.000ZFDA issues guidance regarding drug development for early Alzheimer’s diseasehttps://www.pharmaradar360.com/article/cfd198095cb7760cPharmaRadar360en2026-04-08T19:45:17.000ZFDA Announces New Quality Oversight Webpagehttps://www.pharmaradar360.com/article/c25e09efbeb1ebd7PharmaRadar360en2026-04-08T19:43:52.000ZFDA establishes CDER Center for Clinical Trial Innovation (C3TI)https://www.pharmaradar360.com/article/df9ea288dc0a278bPharmaRadar360en2026-04-08T19:41:22.000ZFDA issues agency-initiated proposed order regarding OTC monograph drugs containing acetaminophenhttps://www.pharmaradar360.com/article/083772a215c0308fPharmaRadar360en2026-04-08T19:40:48.000ZFDA updates guidance on interchangeabilityhttps://www.pharmaradar360.com/article/03e16993a733eb73PharmaRadar360en2026-04-08T19:39:19.000ZFDA's ISTAND Pilot Program accepts a submission of first organ-on-a-chip technology designed to predict human drug-induced liver injury (DILI)https://www.pharmaradar360.com/article/ef48c2f3a79c78ccPharmaRadar360en2026-04-08T19:38:03.000ZFDA clarifies policies for compounders as national GLP-1 supply begins to stabilizehttps://www.pharmaradar360.com/article/502649853e56f8aePharmaRadar360en2026-04-08T19:37:25.000ZFDA approves REMS modification, advancing new drug disposal optionhttps://www.pharmaradar360.com/article/6b53c148356fbaf3PharmaRadar360en2026-04-08T18:30:54.167ZSigns You May Need a New Pillowhttps://www.pharmaradar360.com/article/e80c22b3a4bc5d28PharmaRadar360en2026-04-08T16:05:00.000ZAbbVie moves to close loopholes and strengthen accountability in 340B programhttps://www.pharmaradar360.com/article/55af2a71d1758243PharmaRadar360en2026-04-08T16:00:00.000ZUK formalizes zero tariffs deal with US, will pay more for drugshttps://www.pharmaradar360.com/article/1e8b5d1ef6c358f2PharmaRadar360en2026-04-08T12:00:00.000ZExdensur (depemokimab) approved in China for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP)https://www.pharmaradar360.com/article/42c4a359fb6c3c85PharmaRadar360en2026-04-08T12:00:00.000ZShujie Yang harnesses sound to build the next generation of microrobotic medicinehttps://www.pharmaradar360.com/article/d1140638ffe45faaPharmaRadar360en2026-04-08T12:00:00.000ZBOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Yearhttps://www.pharmaradar360.com/article/443bc79f436d33cfPharmaRadar360en2026-04-08T11:01:00.000ZPrecision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conferencehttps://www.pharmaradar360.com/article/9e1cab0f347c6ff0PharmaRadar360en2026-04-08T11:00:00.000ZPesticides may wreak havoc on the gut microbiomehttps://www.pharmaradar360.com/article/88ec9cf4278c12f1PharmaRadar360en2026-04-08T10:12:08.000ZBoletín sobre Medicamentos Veterinarios. Enero-Marzo 2026https://www.pharmaradar360.com/article/3c8fa9f878fb648cPharmaRadar360en2026-04-08T10:00:00.000ZThe Ultimate Guide to New USP Bioburden Standards: Navigating Compliance & Market Success in 2026https://www.pharmaradar360.com/article/0735d31535df2708PharmaRadar360en2026-04-08T09:37:32.000ZDigital upgrade to histopathology service reduces wait time for cancer diagnosishttps://www.pharmaradar360.com/article/b529e0a735901334PharmaRadar360en2026-04-08T09:16:18.000ZFDA Seeks Input on Digital Health Technologies in Clinical Investigations for Drugs and Biological Productshttps://www.pharmaradar360.com/article/5d845a3a6343893cPharmaRadar360en2026-04-08T07:00:10.000ZNotice Regarding Issuance of New Shares and Secondary Offering of Shareshttps://www.pharmaradar360.com/article/aec189315eaa11ecPharmaRadar360en2026-04-08T07:00:00.000ZNotice Regarding Refinancing of Existing Borrowings through a Bridge Loan